Risk Assessment of Thromboembolic Disease In Patients Treated For Multiple Myeloma

被引：0
|
作者：
Douma, Soukaina [1 ]
Naim, Sara [1 ]
Benmoussa, Amine [1 ]
Berrada, Sophia [1 ]
Lamchahab, Mouna [1 ]
Khoubila, Nissrine [1 ]
Rachid, Mohammed [1 ]
Qachouh, Meryem [1 ]
Cherkaoui, Siham [1 ]
Madani, Abdellah [1 ]
机构：
[1] Univ Hosp, Ctr IBN ROCHD, Casablanca, Morocco
来源：
CLINICAL LYMPHOMA MYELOMA & LEUKEMIA | 2024年 / 24卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
MM-556
引用
收藏
页码：S570 / S570
页数：1
相关论文
共 50 条
  • [41] Risk of Hypertension (HTN) and Malignant Hypertension (mHTN) in Patients Treated for Multiple Myeloma (MM)
    Chari, Ajai
    Aggarwal, Sanjay
    Mezzi, Khalid
    Zhu, Shao
    Werther, Winifred
    Felici, Diana
    Lyon, Alexander R.
    PHARMACOEPIDEMIOLOGY AND DRUG SAFETY, 2016, 25 : 91 - 91
  • [42] Incidence and risk of hypertension in patients newly treated for multiple myeloma: a retrospective cohort study
    Ajai Chari
    Khalid Mezzi
    Shao Zhu
    Winifred Werther
    Diana Felici
    Alexander R. Lyon
    BMC Cancer, 16
  • [43] Incidence and risk of hypertension in patients newly treated for multiple myeloma: a retrospective cohort study
    Chari, Ajai
    Mezzi, Khalid
    Zhu, Shao
    Werther, Winifred
    Felici, Diana
    Lyon, Alexander R.
    BMC CANCER, 2016, 16
  • [44] INCREASED RISK OF NEW ONSET OF ARTERIAL HYPERTENSION IN PATIENTS WITH MULTIPLE MYELOMA TREATED WITH CARLFIZOMIB
    Cicco, Sebastiano
    De Fazio, Giuditta
    Marozzi, Marialuisa Sveva
    Melaccio, Assunta
    Cavallo, Michele
    Solimando, Antonio Giovanni
    Vacca, Angelo
    Ria, Roberto
    JOURNAL OF HYPERTENSION, 2023, 41 : E134 - E135
  • [45] Cytomegalovirus Reactivation in Patients with Multiple Myeloma Treated with Teclistamab: Risk Factors and Clinical Impact
    Pei, Charles
    Blackburn, Lisa
    Sharma, Nidhi
    Bumma, Naresh
    Khan, Abdullah Mohammad
    Devarakonda, Srinivas
    Umyarova, Elvira
    Benson, Don
    Rosko, Ashley
    El Boghdadly, Zeinab
    Cottini, Francesca
    BLOOD, 2024, 144 : 4717 - 4718
  • [46] Incidence and risk of cardiac toxicities in patients with relapsed and refractory multiple myeloma treated with carfilzomib
    Zhao, Fang
    Yang, Bo
    Wang, Juan
    Zhang, Rui
    Liu, Jing
    Yin, Fenglei
    Xu, Weixing
    He, Chunyuan
    DRUG DESIGN DEVELOPMENT AND THERAPY, 2018, 12 : 1525 - 1531
  • [47] Risk of hypertension (HTN) and malignant hypertension (mHTN) in patients treated for multiple myeloma (MM).
    Chari, Ajai
    Aggarwal, Sanjay
    Mezzi, Khalid
    Zhu, Shao
    Werther, Winifred
    Felici, Diana
    Lyon, Alexander R.
    JOURNAL OF CLINICAL ONCOLOGY, 2016, 34 (15)
  • [48] RISK OF HYPERTENSION (HTN) AND MALIGNANT HYPERTENSION (MHTN) IN PATIENTS TREATED FOR MULTIPLE MYELOMA (MM)
    Mezzi, K.
    Chari, A.
    Aggarwal, S.
    Zhu, S.
    Werther, W.
    Felici, D.
    Lyon, A.
    HAEMATOLOGICA, 2016, 101 : 795 - 795
  • [49] Incidence and Risk of Cardiac Events in Patients With Previously Treated Multiple Myeloma Versus Matched Patients Without Multiple Myeloma: An Observational, Retrospective, Cohort Study
    Kistler, Kristin D.
    Kalman, Jill
    Sahni, Gagan
    Murphy, Brian
    Werther, Winifred
    Rajangam, Kanya
    Chari, Ajai
    CLINICAL LYMPHOMA MYELOMA & LEUKEMIA, 2017, 17 (02): : 89 - 96
  • [50] Assessment of cardiovascular disease risk factors in patients treated for schizophrenia
    Tylec, Aneta
    Skalecki, Maciej
    Ziemecki, Piotr
    Brzozowska, Agnieszka
    Dubas-Slemp, Halina
    Kucharska, Katarzyna
    PSYCHIATRIA POLSKA, 2019, 53 (06) : 1305 - 1319
12345